Cargando…
Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs
BACKGROUND: The intestinal tract is a rich and complex environment and its microbiota has been shown to have an important role in health and disease in the host. Several factors can cause disruption of the normal intestinal microbiota, including antimicrobial therapy, which is an important cause of...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323147/ https://www.ncbi.nlm.nih.gov/pubmed/25644524 http://dx.doi.org/10.1186/s12917-015-0335-7 |
_version_ | 1782356501484011520 |
---|---|
author | Costa, Marcio C Stämpfli, Henry R Arroyo, Luis G Allen-Vercoe, Emma Gomes, Roberta G Weese, J Scott |
author_facet | Costa, Marcio C Stämpfli, Henry R Arroyo, Luis G Allen-Vercoe, Emma Gomes, Roberta G Weese, J Scott |
author_sort | Costa, Marcio C |
collection | PubMed |
description | BACKGROUND: The intestinal tract is a rich and complex environment and its microbiota has been shown to have an important role in health and disease in the host. Several factors can cause disruption of the normal intestinal microbiota, including antimicrobial therapy, which is an important cause of diarrhea in horses. This study aimed to characterize changes in the fecal bacterial populations of healthy horses associated with the administration of frequently used antimicrobial drugs. RESULTS: Twenty-four adult mares were assigned to receive procaine penicillin intramuscularly (IM), ceftiofur sodium IM, trimethoprim sulfadiazine (TMS) orally or to a control group. Treatment was given for 5 consecutive days and fecal samples were collected before drug administration (Day 1), at the end of treatment (Days 5), and on Days 14 and 30 of the trial. High throughput sequencing of the V4 region of the 16S rRNA gene was performed using an Illumina MiSeq sequencer. Significant changes of population structure and community membership were observed after the use of all drugs. TMS caused the most marked changes on fecal microbiota even at higher taxonomic levels including a significant decrease of richness and diversity. Those changes were mainly due to a drastic decrease of Verrucomicrobia, specifically the “5 genus incertae sedis”. Changes in structure and membership caused by antimicrobial administration were specific for each drug and may be predictable. Twenty-five days after the end of treatment, bacterial profiles were more similar to pre-treatment patterns indicating a recovery from changes caused by antimicrobial administration, but differences were still evident, especially regarding community membership. CONCLUSIONS: The use of systemic antimicrobials leads to changes in the intestinal microbiota, with different and specific responses to different antimicrobials. All antimicrobials tested here had some impact on the microbiota, but TMS significantly reduced bacterial species richness and diversity and had the greatest apparent impact on population structure, specifically targeting members of the Verrucomicrobia phylum. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-015-0335-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4323147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43231472015-02-11 Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs Costa, Marcio C Stämpfli, Henry R Arroyo, Luis G Allen-Vercoe, Emma Gomes, Roberta G Weese, J Scott BMC Vet Res Research Article BACKGROUND: The intestinal tract is a rich and complex environment and its microbiota has been shown to have an important role in health and disease in the host. Several factors can cause disruption of the normal intestinal microbiota, including antimicrobial therapy, which is an important cause of diarrhea in horses. This study aimed to characterize changes in the fecal bacterial populations of healthy horses associated with the administration of frequently used antimicrobial drugs. RESULTS: Twenty-four adult mares were assigned to receive procaine penicillin intramuscularly (IM), ceftiofur sodium IM, trimethoprim sulfadiazine (TMS) orally or to a control group. Treatment was given for 5 consecutive days and fecal samples were collected before drug administration (Day 1), at the end of treatment (Days 5), and on Days 14 and 30 of the trial. High throughput sequencing of the V4 region of the 16S rRNA gene was performed using an Illumina MiSeq sequencer. Significant changes of population structure and community membership were observed after the use of all drugs. TMS caused the most marked changes on fecal microbiota even at higher taxonomic levels including a significant decrease of richness and diversity. Those changes were mainly due to a drastic decrease of Verrucomicrobia, specifically the “5 genus incertae sedis”. Changes in structure and membership caused by antimicrobial administration were specific for each drug and may be predictable. Twenty-five days after the end of treatment, bacterial profiles were more similar to pre-treatment patterns indicating a recovery from changes caused by antimicrobial administration, but differences were still evident, especially regarding community membership. CONCLUSIONS: The use of systemic antimicrobials leads to changes in the intestinal microbiota, with different and specific responses to different antimicrobials. All antimicrobials tested here had some impact on the microbiota, but TMS significantly reduced bacterial species richness and diversity and had the greatest apparent impact on population structure, specifically targeting members of the Verrucomicrobia phylum. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-015-0335-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-03 /pmc/articles/PMC4323147/ /pubmed/25644524 http://dx.doi.org/10.1186/s12917-015-0335-7 Text en © Costa et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Costa, Marcio C Stämpfli, Henry R Arroyo, Luis G Allen-Vercoe, Emma Gomes, Roberta G Weese, J Scott Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs |
title | Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs |
title_full | Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs |
title_fullStr | Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs |
title_full_unstemmed | Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs |
title_short | Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs |
title_sort | changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323147/ https://www.ncbi.nlm.nih.gov/pubmed/25644524 http://dx.doi.org/10.1186/s12917-015-0335-7 |
work_keys_str_mv | AT costamarcioc changesintheequinefecalmicrobiotaassociatedwiththeuseofsystemicantimicrobialdrugs AT stampflihenryr changesintheequinefecalmicrobiotaassociatedwiththeuseofsystemicantimicrobialdrugs AT arroyoluisg changesintheequinefecalmicrobiotaassociatedwiththeuseofsystemicantimicrobialdrugs AT allenvercoeemma changesintheequinefecalmicrobiotaassociatedwiththeuseofsystemicantimicrobialdrugs AT gomesrobertag changesintheequinefecalmicrobiotaassociatedwiththeuseofsystemicantimicrobialdrugs AT weesejscott changesintheequinefecalmicrobiotaassociatedwiththeuseofsystemicantimicrobialdrugs |